Krebs Biochemicals & Industries has informed that the meeting of Board of Directors of the Company is scheduled to be held on Friday, 26th May 2017 to consider and approve the audited financial results along with the auditor’s report for the year ended 31st March, 2017; Any other matter with the permission of the Chair. Further, in connection to the above, trading window for dealing in shares of the Company will remain closed for the specified persons as defined in the Code from 19th May, 2017 and shall re-open 48 hours after the publication of the results to the public.
The above information is a part of company’s filings submitted to BSE.
